Akebia Therapeutics (AKBA) Debt Ratio (2018 - 2026)
Akebia Therapeutics' Debt Ratio came in at 0.14 for Q2 2026, up 4.1% from 0.14 a year earlier and up 5.1% from the prior quarter.
Analysis
Akebia Therapeutics (AKBA) Debt Ratio (2018 - 2026) Analysis & Trends
For FY2025, Akebia Therapeutics' Debt Ratio was 0.13, down 26.9% from FY2024.
- Going back by year, Debt Ratio was 0.18 in FY2024 (+22.2%), 0.14 in FY2023 (-22.7%), 0.19 in FY2022 (+0.7%) and 0.18 in FY2021 (+23.2%).
- The Q2 2026 figure represents the highest quarterly Debt Ratio since Q1 2025.
- Year-over-year, Debt Ratio increased in four of the last eight quarters, with an average decline of 5.9%.
- The fastest year-over-year change in Debt Ratio over five years came in Q3 2021 (growth of 42.5%), and the weakest in Q3 2025 (a decline of 29.3%).
- Business Quant data shows AKBA's Debt Ratio at 0.13 (Q1 2026), 0.13 (Q4 2025) and 0.13 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.31 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.60 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.53 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Akebia Therapeutics | 241.85 Mn | -427.63 Mn | 38.70 Mn | 0.14 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.14 |
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.13 |
| Jun 30, 2025 | 0.14 |
| Mar 31, 2025 | 0.15 |
| Dec 31, 2024 | 0.18 |
| Sep 30, 2024 | 0.19 |
| Jun 30, 2024 | 0.17 |
| Mar 31, 2024 | 0.13 |
| Dec 31, 2023 | 0.14 |
| Sep 30, 2023 | 0.18 |
| Jun 30, 2023 | 0.17 |
| Mar 31, 2023 | 0.18 |
| Dec 31, 2022 | 0.19 |
| Sep 30, 2022 | 0.15 |
| Jun 30, 2022 | 0.19 |
| Mar 31, 2022 | 0.18 |
| Dec 31, 2021 | 0.18 |
| Sep 30, 2021 | 0.16 |
API Access
Akebia Therapeutics Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=AKBA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();